The
Transfusion News email appeared in my in-box this morning. Not a lot of
immediate relevance to me, but quite a bit of peripheral interest…
Successful Treatment of Refractory B-cell Lymphomas with CAR T-Cell Therapy
January 3, 2018
Chimeric antigen receptor (CAR) T-cell therapy has been shown to successfully treat refractory B-cell lymphomas. Two new studies published in The New England Journal of Medicine confirm that CAR T-cell therapy can be used to treat B-cell lymphoma patients who have not responded to standard therapies. [Read More]
Gene Therapy for Hemophilia A Patients Successful
December 28, 2017
Gene therapy using adeno-associated viral (AAV) vectors has been successfully used to treat patients with hemophilia B. Gene therapy for hemophilia A has been more difficult since the coding region of factor VIII is too large for AAV vectors. As described in The New England Journal of Medicine, researchers circumvented the problem by using the [Read More]
Variation in Practice to Reduce Transfusion-Transmitted Cytomegalovirus
December 20, 2017
While cytomegalovirus (CMV) infections are usually asymptomatic, they can be life-threatening for neonates, transplant recipients, and other immunosuppressed patients receiving transfusions. Data on the best preventative measures to reduce transfusion-transmitted CMV are lacking. In order to gain a better understanding of preventive strategies used in various medical institutions, the College of American Pathologists (CAP) Transfusion [Read More]
What I Wish I Knew! with Pat Kopko
January 8, 2018 | BBGuy Podcast
What happens when two BB/TM docs who've known each other for 30+ years get together to talk? Tons of essential tips that will help YOU understand Transfusion Medicine more! [Listen Now]
January 8, 2018 | BBGuy Podcast
What happens when two BB/TM docs who've known each other for 30+ years get together to talk? Tons of essential tips that will help YOU understand Transfusion Medicine more! [Listen Now]
No comments:
Post a Comment